Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/28/2011 | US20110097355 Virus-like particles as vaccines for paramyxovirus |
04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
04/28/2011 | US20110097339 Compositions monovalent for CD28 binding and methods of use |
04/28/2011 | US20110097332 Composition and Method of Use for HCV Immunization |
04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
04/28/2011 | US20110097322 Partially loaded antibodies and methods of their conjugation |
04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
04/28/2011 | US20110097305 Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Cell Cycle Inhibitors |
04/28/2011 | US20110097303 Methods and compositions for treating and preventing viral infections |
04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
04/28/2011 | US20110097270 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
04/28/2011 | DE102009050854A1 Verwendung von Menthylethern als antibakterielle, antimycotische oder antivirale Wirkstoffe Use of Menthylethern as antibacterial, antifungal, or antiviral agents |
04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
04/28/2011 | CA2778414A1 Herbal composition comprising ginger and goldenrod for the treatment of cold and flu |
04/28/2011 | CA2778359A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
04/28/2011 | CA2777824A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
04/28/2011 | CA2777187A1 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents |
04/28/2011 | CA2774910A1 Novel acylpiperazinones and their use as pharmaceuticals |
04/28/2011 | CA2773210A1 Derivatives of n-hydroxybenzamide for treating hiv infections |
04/27/2011 | EP2314719A1 S. pneumoniae antigens |
04/27/2011 | EP2314718A1 S. pneumoniae antigens |
04/27/2011 | EP2314712A1 Expression vectors encoding epitopes of antigens and methods for their design |
04/27/2011 | EP2314697A1 Streptococcus pneumoniae proteins and nucleic acids |
04/27/2011 | EP2314693A2 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
04/27/2011 | EP2314630A1 Method of producing immunogenic lipopeptides comprising T-helper and Cytotoxic T Lymphocyte (CTL) epitopes |
04/27/2011 | EP2314621A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
04/27/2011 | EP2314599A1 Glycopeptide antibiotic monomer derivatives |
04/27/2011 | EP2314591A1 Pseudopolymorphic forms of a hiv protease inhibitor |
04/27/2011 | EP2314582A1 Heterocyclic compounds as antiviral agents |
04/27/2011 | EP2314349A1 Anti-viral griffithsin compounds, compositions, and methods of use |
04/27/2011 | EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies |
04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
04/27/2011 | EP2314294A2 3,3'-diindolylmethane immune activating compositions |
04/27/2011 | EP2314293A1 Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases |
04/27/2011 | EP2314283A1 Composition comprising anisic acid and an acid buffer |
04/27/2011 | EP2313408A1 Diketopiperidine derivatives as hiv attachment inhibitors |
04/27/2011 | EP2313402A1 Heterocyclic urea derivatives and methods of use thereof |
04/27/2011 | EP2313395A1 Pyridone and pyridazone analogues as gpr119 modulators |
04/27/2011 | EP2313112A2 Neutralizing anti-influenza a virus antibodies and uses thereof |
04/27/2011 | EP2313111A1 Toll-like receptor agonist formulations and their use |
04/27/2011 | EP2313099A2 Use of rifalazil to treat colonic disorders |
04/27/2011 | EP2312952A1 Antimicrobial composition |
04/27/2011 | EP2102199B1 Antibacterial polycyclic urea compounds |
04/27/2011 | EP2001862B1 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
04/27/2011 | EP1368373B1 Environmentally regulated genes, involved in the virulence of streptococcus suis |
04/27/2011 | EP1303541B1 Compositions containing metronidazole |
04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
04/27/2011 | CN201806327U Constitution health preserving mattress |
04/27/2011 | CN1970556B 1-furfuryl-3-substituted Indolinyl-2-one derivative, its preparation method and uses |
04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
04/27/2011 | CN102037013A Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes |
04/27/2011 | CN102037006A Anti-bacterial compositions |
04/27/2011 | CN102036996A Bridged heterocycles as HIV integrase inhibitors |
04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
04/27/2011 | CN102036714A Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid |
04/27/2011 | CN102036658A Combination therapy for the treatment of influenza |
04/27/2011 | CN102031278A Method for enzymatic synthesis of trehalose unsaturated fatty acid diester in organic phase |
04/27/2011 | CN102031262A Construction method and application of faeG expressing gene engineering probiotic |
04/27/2011 | CN102031235A Enterococcus faecium ANSE228 and application thereof |
04/27/2011 | CN102031234A Bacillussubtilis for decomposing aflatoxin and active protein secreted by same |
04/27/2011 | CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof |
04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
04/27/2011 | CN102030819A Broad spectrum polypeptin and application thereof |
04/27/2011 | CN102030809A Theasapogenol derivative with antibacterial effect as well as preparation method and application thereof |
04/27/2011 | CN102030807A Theasapogenol derivative with anti-HIV (Human Immunodeficiency Virus) activity, preparation method and application thereof |
04/27/2011 | CN102030799A Cycloastragenol-6-O-beta-D glucoside monohydrate and crystal thereof |
04/27/2011 | CN102030791A Four tiacumicin compounds as well as preparation methods and applications thereof in preparing antimicrobial agents |
04/27/2011 | CN102030766A Flomoxef antibiotic containing pyrrolinheterocycle |
04/27/2011 | CN102030764A 4,5-dihydro-thiazinogeldanamycin and preparation method thereof |
04/27/2011 | CN102030737A Clinafloxacin amino derivatives and application thereof |
04/27/2011 | CN102030615A High-clarity aqueous concentrates of 4-hexylresorcinol |
04/27/2011 | CN102028965A Mugwort related extraction part medicinal property-based air freshener |
04/27/2011 | CN102028961A Ultrasonic coupling agent used by traumatic patient after surgery |
04/27/2011 | CN102028950A Preparation for promoting stability of ceftriaxone sodium granules |
04/27/2011 | CN102028946A Taxus mairei immunological adjuvant and influenza vaccine containing same |
04/27/2011 | CN102028945A Spirulina polysaccharide immune adjuvant and influenza vaccine containing the same |
04/27/2011 | CN102028944A Combination vaccines with low dose of hib conjugate |
04/27/2011 | CN102028943A Respiratory syncytial virus-like particle vaccine and preparation method thereof |
04/27/2011 | CN102028942A Application of Escherichia coli in fish vaccine |
04/27/2011 | CN102028941A Neisseria meningitidis group B recombinant protein chimeric vaccine and preparation method thereof |
04/27/2011 | CN102028940A Edwardsiella tarda surface display type vaccine and preparation and application thereof |
04/27/2011 | CN102028935A Method for forecasting, preventing and treating septicemia and septic shock and kit |
04/27/2011 | CN102028933A Medicinal composition containing lipid material nocathiacin antibiotic |
04/27/2011 | CN102028912A Externally applied traditional Chinese medicine powder for diminishing inflammation and swelling |
04/27/2011 | CN102028911A External medicament for treating tinea pedis |
04/27/2011 | CN102028907A Traditional Chinese medicinal preparation for treating yellow scour of newborn piglets |
04/27/2011 | CN102028888A Method for preparing Chinese medicinal composition for treating cold |
04/27/2011 | CN102028886A Chinese medicinal preparation for treating tetanus |
04/27/2011 | CN102028877A Medicament for treating toxoplasm, rubella virus, cytomegalovirus and herpes simplex virus (TORCH) infection syndrome |
04/27/2011 | CN102028861A New liver and kidney nourishing decoction preparation (novel medicament delivery system) and preparation method thereof |
04/27/2011 | CN102028851A Formula of foot bath Chinese medicine for treating dermatophytosis |
04/27/2011 | CN102028826A Chinese medicinal composition for treating recurrent and chronic tonsillitis |